People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathos AI, Inc. | — | Biotechnology | Series D+ | $365.0M | $2.4B | 2025 |
| Viela Bio, Inc. | — | Biotechnology | Series D+ | $357.3M | $3.1B | 2018 |
| PhaseBio Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $102.1M | $912.3M | 2018 |
| Cerapedics Inc | — | Biotechnology | Series B | $99.1M | $492.3M | 2018 |
| Nucleus Radiopharma, Inc. | — | Other Health Care | Series C | $72.1M | $662.9M | 2022 |
| Corvidia Therapeutics, Inc. | — | Biotechnology | Series C | $60.0M | $2.5B | 2018 |
Tyrell Rivers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tyrell Rivers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Clay Thorp | 1 | 10 |
| Mohamad Makhzoumi | 1 | 10 |
| Jonathan Silverstein | 1 | 10 |
| Chau Khuong | 1 | 9 |
| Eric Lefkofsky | 1 | 8 |
| Justin Klein | 1 | 6 |
| Aaron Kantoff | 1 | 6 |
| Noah Kroloff | 1 | 6 |
| Justin Butler | 1 | 5 |
| Linda Tufts | 1 | 5 |
| Amit Mehta | 1 | 4 |
| Chen Schor | 1 | 4 |
| Marc De Garidel | 1 | 3 |
| Christopher Prior | 1 | 3 |
| Graziano Seghezzi | 1 | 3 |
| Jonathan Mow | 1 | 3 |
| Glen Kashuba | 1 | 3 |
| Antony Koblish | 1 | 3 |
| Asish K Xavier | 1 | 3 |
| Douglas K Reed | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.